Y-Intercept (HK)’s West Pharmaceutical WST Stock Holding History

Y-Intercept (HK)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,667	Closed	-$2.93M	–	2114
2025 Q4	$2.93M	Buy	+10,667	New	+$2.92M	0.07%	435
2025 Q3	–	Sell	-14,874	Closed	-$3.25M	–	2109
2025 Q2	$3.25M	Buy	14,874 +6,676	+81%	+$1.43M	0.08%	375
2025 Q1	$1.84M	Buy	+8,198	New	+$2.26M	0.12%	215
2024 Q3	–	Sell	-5,187	Closed	-$1.71M	–	1867
2024 Q2	$1.71M	Buy	+5,187	New	+$1.83M	0.09%	290
2023 Q4	–	Sell	-2,597	Closed	-$974K	–	1701
2023 Q3	$974K	Buy	2,597 +1,402	+117%	+$542K	0.1%	322
2023 Q2	$457K	Buy	+1,195	New	+$427K	0.05%	588
2023 Q1	–	Sell	-3,740	Closed	-$880K	–	1591
2022 Q4	$880K	Sell	3,740 -6,103	-62%	-$1.45M	0.13%	237
2022 Q3	$2.42M	Buy	+9,843	New	+$3M	0.24%	112
2021 Q4	–	Sell	-3,310	Closed	-$1.41M	–	922
2021 Q3	$1.41M	Buy	+3,310	New	+$1.4M	0.26%	120
2021 Q1	–	Sell	-1,747	Closed	-$489K	–	830
2020 Q4	$489K	Buy	+1,747	New	+$490K	0.21%	158

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Y-Intercept (HK)'s WST Position: Q1 2026 in Review

Y-Intercept (HK) sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 10,667 shares — an estimated $2.93M sold.

Y-Intercept (HK) first reported a position in WST in Q4 2020 and held it in 10 quarters. The position peaked at $3.25M in Q2 2025. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Y-Intercept (HK) reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Y-Intercept (HK) sold 10,667 West Pharmaceutical shares in Q1 2026, an estimated $2.93M.
Y-Intercept (HK) first reported a position in West Pharmaceutical in Q4 2020 and held it in 10 quarters.
Y-Intercept (HK)'s West Pharmaceutical position peaked at $3.25M in Q2 2025.
755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.